brain cancer

Waltham, Massachusetts, U.S., September 21, 2026 Mercy BioAnalytics, Inc. has announced that the U.S. Food and Drug Administration (FDA)...

Uppsala, Sweden, September 22, 2026 Beactica Therapeutics AB has announced the initiation of IND-enabling studies for BEA-17, its wholly...

MELBOURNE, Australia and INDIANAPOLIS, Ind. — September 14, 2026 Telix Pharmaceuticals announced that the U.S. Food and Drug Administration...

London, UK, September 9, 2026 Full-Life Technologies has announced that the U.S. Food and Drug Administration (FDA) has cleared...

Tel Aviv, Israel, and Oslo, Norway, September 10, 2026 BioLineRx Ltd. and Hemispherian AS have announced that two abstracts...

SEATTLE, Washington and CAMBRIDGE, Massachusetts — September 8, 2026 BrainChild Bio, Inc. announced the initiation of the pivotal Phase...

PROVIDENCE, R.I., August 18, 2026 GT Medical Technologies, Inc. announced new clinical findings suggesting that its GammaTile® targeted radiation...

Houston, Texas, August 14, 2026 Cerenome, Inc. reported continued progress across its integrated central nervous system (CNS) oncology platform,...

MALLORCA, Spain, July 23, 2026 Laminar Pharmaceuticals S.A. has announced the successful completion of patient recruitment for the CLINGLIO...

NEW YORK, July 20, 2026 Nuvation Bio Inc. has announced positive updated Phase II clinical data for safusidenib, its...